The developments at Holland Capital in 2024 reflect our strong ambitions
Amsterdam/ Düsseldorf, 30th of December 2024 –The developments at Holland Capital in 2024 reflect our strong ambitions. Guided by a focused investment strategy, we continued to actively engage in the high-growth markets of Technology, Healthcare, and Agrifood. Reflecting on a successful year, we completed several key transactions and further strengthened our team.
2024 achievements
- The launch of our fund, Holland Capital Growth and Buy-Out Fund V
- Number of deals in the Netherlands: 5
- Number of add-on acquisitions in the Netherlands: 13
- Number of add-on acquisitions in Germany: 2
- Number of exits: 2
- Number of new colleagues: 4
Sector focus and an entrepreneurial hands-on approach: With specialized sector teams, we focus on the sectors of Healthcare, Technology, and Agrifood, both within the Growth & Buy-out and Venture & Growth segments. We understand the dynamics and opportunities in these sectors and have an extensive network. Holland Capital is not a passive investor; we work closely with management to define and execute strategies. Where needed, our operational team also contributes hands-on to the realization of specific projects within the company.
Which companies would we like to connect with?
- Sector: Technology, Healthcare, and Agrifood
- Positive outlook: Significant growth potential, both autonomous and buy-and-build
- Growth & Buy-out:
- Healthy profitability: cash flow from operations (EBITDA) between EUR 1 – 10m
- Smaller companies: considered as add-on acquisitions for our existing portfolio companies
- Larger companies: considered together with a co-investor
- Venture & Growth:
- Start-ups and scale-ups: EBITDA EUR <1m
- Cash flow negative (in an accelerated growth scenario)
- Revenue EUR 0 – 5m
What to expect from us?
- Flexible approach to transaction structures: We strive to adapt each structure to the needs of the company and its shareholders. Depending on the type of investment, Holland Capital either provides growth capital and/or acquires existing shares. We are flexible regarding the final capital structure: both majority and minority stakes are possible.
- Deal certainty and an efficient process: Thanks to our sector expertise, we are able to quickly assess a business model and put a fair price on the table. Since the partnership with the entrepreneur and/or the management team is the cornerstone of our investment, we devote above-average attention to ensuring the process is completed efficiently, in the right spirit, and with mutual respect for both parties.
- Transparency towards advisors: We appreciate it when advisors involve us early in discussions with entrepreneurs and/or management teams. In such cases, we always ensure that the advisor’s interests are well safeguarded throughout the process. The advisor retains the flexibility to decide whether to represent the sell-side or buy-side in a potential transaction.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare, Technology, and Agrifood-Tech sector.
Yenlo and Fides join forces
Amsterdam, 21 September 2020 – Our portfolio company Yenlo (the integration specialist in the field of API and ESB technology) and Fides (the AFAS migration and integration partner for healthcare and education) join forces to support the integration for customers with...
Holland Capital invests in innovative primary care IT platform HealthConnected
Amsterdam/Alkmaar, September 1st, 2020 – Holland Capital, a Dutch based investment firm, invests in HealthConnected, a healthcare IT platform for the primary care market. This investment enables HealthConnected to focus on the expansion to new regions in the...
Holland Capital investeert in innovatief eerstelijns IT-zorgplatform HealthConnected
Amsterdam/Alkmaar, 1 september 2020 - Participatiemaatschappij Holland Capital investeert in HealthConnected, een IT-zorgplatform voor eerstelijnszorg. Met de investering richt HealthConnected zich op de uitrol naar nieuwe regio’s in Nederland en de verdere...
Sirius Medical haalt EUR 4,4 miljoen op om Sirius Pintuition te lanceren
Sirius Medical haalt EUR 4,4 miljoen op om Sirius Pintuition te lancerenEen innovatieve borstkanker lokalisatie technologie Amsterdam, 14 juli 2020 – Participatiemaatschappij Holland Capital investeert samen met BOM Brabant Ventures en Curie Capital 4,4 miljoen euro...
Sirius Medical raises €4.4M to launch Sirius Pintuition
Sirius Medical raises €4.4M to launch Sirius PintuitionAn innovative breast cancer localization technology Amsterdam, July 14th, 2020 – Investment company Holland Capital invests 4.4 million euros in Sirius Medical together with BOM Brabant Ventures and Curie Capital....
Investeren in Coronatijd: Hubert Verbeek aan het woord
Interview met Hubert Verbeek door Jos Schelfhout van Navigator Network Executive Search. Originele bron. Hubert Verbeek: ‘best practices’ helpt de bedrijven in ons portfolio Een rondje langs investeerders. Met hen bespreken we de huidige ‘Corona-tijd’; hoe kijken zij...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl